Usnic acid attenuates 7,12‐dimethylbenz[a] anthracene (DMBA) induced oral carcinogenesis through inhibiting oxidative stress, inflammation, and cell proliferation in male golden Syrian hamster model

Abstract

AbstractIn this study, we investigated the chemopreventive efficacy of usnic acid (UA), an effective secondary metabolite component of lichens, against 7,12‐dimethylbenz[a]anthracene (DMBA)‐induced oral squamous cell carcinoma (OSCC) in the hamster model. Initially, the buccal pouch carcinogenesis was induced by administering 0.5% DMBA to the HBP (hamster buccal pouch) region about three times a week until the 10th week. Then, UA was orally treated with different concentrations (25, 50, 100 mg/kg b.wt) on alternative days of DMBA exposure, and the experimental process ended in the 16th week. After animal experimentation, we observed 100% tumor incidence with well‐differentiated OSCC, dysplasia, and hyperplasia lesions in the DMBA‐induced HBP region. Furthermore, the UA treatment of DMBA‐induced hamster effectively inhibited tumor growth. In addition, UA upregulated antioxidant levels, interfered with the elevated lipid peroxidation by‐product of thiobarbituric acid reactive substances, and changed the activities of the liver detoxification enzyme (Phase I and II) in DMBA‐induced hamsters. Furthermore, immunohistochemical staining of inflammatory markers (iNOS and COX‐2) and proliferative cell markers (cyclin‐D1 and PCNA) were upregulated in the buccal pouch part of hamster animals induced with DMBA. Notably, the oral administration of UA significantly suppressed these markers during DMBA‐induced hamsters. Collectively, our findings revealed that UA exhibits antioxidant, anti‐inflammatory, antitumor, and apoptosis‐inducing characteristics, demonstrating UA's protective properties against DMBA‐induced HBP carcinogenesis.